Intrinsic value of Prima BioMed Ltd (IMMP)

[per Chepakovich valuation model]

other valuations of IMMP

[per Chepakovich valuation model]  See other valuations of IMMP stock

Previous Close$3.46
Intrinsic Value
Upside potential
Previous Close
$3.46

VALUATION INPUT DATA

Revenue, mln $
Initial revenue growth rate (norm.), %
Variable cost ratio, %
Fixed operating expenses, mln $
Production assets / Revenue, %
Working capital / Revenue, %
Interest rate on debt, %
Life of production assets, yrs
Initial discount rate, %
Shares outstanding, mln
Adjusted equity ratio
Adjusted assets / Revenue
Based on fiscal year data as of 2020-06-30 and quarterly data as of 2020-12-31.
NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.
  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2020(a)2021202220232024202520262027202820292030203120322033203420352036203720382039204020412042204320442045

INCOME STATEMENT

Revenue growth rate, %106.9NaN
Revenue, $11NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m19NaN
Operating income, $m-8NaN
EBITDA, $m-7NaN
Interest expense (income), $mNaN
Earnings before tax, $m-9NaN
Tax expense, $m0NaN
Net income, $m-9NaN

BALANCE SHEET

Cash and short-term investments, $m18NaN
Total assets, $m31NaN
Adjusted assets (=assets-cash), $m14NaN
Average production assets, $m11NaN
Working capital, $m19NaN
Total debt, $m6NaN
Total liabilities, $m9NaN
Total equity, $m22NaN
Debt-to-equity ratio0.264NaN
Adjusted equity ratio0.344NaN

CASH FLOW

Net income, $m-9NaN
Depreciation, amort., depletion, $m1NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-7NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-0NaN
Free cash flow, $m-7NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m19
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN